Danae A. Delivanis, MD; Victor M. Montori, MD, MSc
Delivanis DA, Montori VM. In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD. Ann Intern Med. 2015;162:JC11. doi: 10.7326/ACPJC-2015-162-8-011
Download citation file:
Published: Ann Intern Med. 2015;162(8):JC11.
Learn more about subscription options.
Register Now for a free account.
Cardiology, Chronic Kidney Disease, Coronary Risk Factors, Diabetes, Diabetic Nephropathy.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only